Sequence Motifs Specifying Homing and Metastasis to Bone

Abstract

We are using a novel approach developed at our Institute which makes use of random peptide libraries expressed on the surface of filamentous phage in order to identify in vivo peptides that may confer preferential homing properties to cancer cells for bone tissue. This approach is also complemented by in vitro panning using immortalized bone marrow stromal and endothelial cells as well as by expression cloning of cDNAs expressed differentially by metastatic breast cancer cells. To-date we have identified 10 peptides that appear to home to bone marrow by in vivo selection and one additional peptide that was positive in our in vitro selection system. Furthermore we have succeeded in immortalizing eleven different bone marrow cell lines which will be useful in our expression cloning experiments. These experimental approaches may lead to the identification of peptide sequences effective in blocking metastasis and serve as therapeutic compounds. This may lead to uncovering the basic mechanisms of bone metastasis by cancer cells which remains today one of the fundamental unresolved problems in tumor biology. Furthermore, identification of bone-specific homing sequences would enable the design of vectors to be used in gene therapy of genetic diseases affecting bone.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 1999
Accession Number
ADA384097

Entities

People

  • Jose L. Millan

Organizations

  • Sanford Burnham Prebys Medical Discovery Institute

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Bone Marrow
  • Bone Marrow Cells
  • Breast Cancer
  • Cancer
  • Cell Line
  • Cells
  • Endothelial Cells
  • Gene Therapy
  • Genetic Structures
  • Identification
  • Metastasis
  • Molecules
  • Neoplasms
  • Proteins
  • Sequences
  • Stromal Cells

Fields of Study

  • Biology

Readers

  • Molecular Genetics
  • Oncology (Cancer Research).
  • Systems Analysis and Design

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech